Skip to main content
OpenTrials

Clinical trial condition

Treatment-refractory Acute Graft-versus-Host Disease

Explore clinical trials studying Treatment-refractory Acute Graft-versus-Host Disease. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Treatment-refractory Acute Graft-versus-Host Disease trial results

Completed

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

NCT03327857

Conditions
Steroid-refractory Acute Graft-versus-host Disease, Treatment-refractory Acute Graft-versus-Host Disease
Locations
  • City of Hope Duarte, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 13 locations
View Trial Details

Related conditions